Led · Equity · Mar 2026

Founded in 2021, Flotte built its reputation on fashion-forward reinterpretations of rainwear and has expanded its range since 2025 into a broader seasonal wardrobe including accessories and apparel. The brand emphasizes sustainable materials, using recycled fabrics as part of its product positioning. Flotte reported 70% growth for 2025, employs 25 people, and is approaching €10 million in sales driven by about 600 retail partners and a strong online channel (roughly 50% retail, 40% online). Management plans to accelerate retail expansion with a new store in Lyon opening in April and two further boutiques scheduled for late 2026 to early 2027. The company is also pursuing international distribution in Belgium, Germany, Spain, the Netherlands and select department stores in Japan and South Korea. Flotte combines community-driven marketing and staged brand activations with an aim to scale its retail footprint and team structure following the recent fundraise.

Led · Series A · Dec 2021

HypnoVR is a market leader in digital therapies that combines medical hypnosis with immersive virtual reality to manage pain and stress. Its digital medical hypnosis solution has been clinically validated and is used as a non-pharmacological anesthesia to reduce pain, anxiety and general discomfort during medical procedures. The therapy is deployed in operating rooms and across specialist fields such as dental care, oncology, urology, gynecology and medical imaging, and can also help healthcare professionals manage workplace stress. More than 240 healthcare institutions across Europe currently use HypnoVR's technology. The company is ISO 13485 certified. The €4.5M Series A will fund acceleration of commercial roll-out in France and internationally and increased R&D to improve therapeutic efficacy and broaden clinical applications. HypnoVR is a Strasbourg, France-based developer of virtual reality software that enables large-scale deployment of medical hypnosis to manage pain, stress and anxiety. Co-founded by Dr. Denis Graff, Dr. Chloé Chauvin and Nicolas Schaettel, the company uses commercially available headsets such as Oculus Rift and Samsung Gear to deliver intense multisensory tridimensional immersion experiences. The technology is in the final stages of obtaining a class 1 medical device CE marking and is currently being used in applications for pediatric surgery, gastroenterology, gynecology and dental surgery. In September 2018 the company will bring to market its medical hypnosis virtual reality solution. The company secured €700k in seed funding to pursue product development and reinforce its sales and marketing team.

Participated · Equity · Nov 2021

Moonbird is a Belgian healthtech startup founded in 2019 that offers a palm-sized breathing device paired with an app. The handheld device slows breathing, monitors heart rate, and lets users track progress through short, guided exercises to calm anxiety and fall asleep faster. Founders Stefanie and Michael Broes developed the product after seeing friends and family struggle with insomnia and anxiety. After a successful rollout in Belgium, the company is expanding into other European countries. Moonbird raised €1.5M in a growth round to fund international expansion and scale distribution of its compact, discreet device based on scientifically proven breathing principles.

Participated · Series A · Jan 2020

Calltic develops a fast detection solution that identifies on-net and off-net SIMBoxes with a single tool, claiming performance superior to CDR-based approaches. Founded in 2017 and based in Ghent, the company has begun commercial traction with initial contracts for mobile operators in Africa. Calltic plans to roll out its first product in 2020 and is preparing additional product introductions. The company has filed its first patent to protect its technological core. With the newly closed financing, Calltic intends to execute its go-to-market and product rollout plans. To date the company has raised nearly €2 million for technology and business development.